Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.
Timm GreulichAnna AlbertWerner CasselTobias BoeseltErika PeychevAndreas KlemmerFrancini FerreiraChristian F ClarenbachMaria L Torres-DuranAlice Margaret TurnerMarc MiravitllesPublished in: International journal of chronic obstructive pulmonary disease (2022)
There is a high variability in the criteria for prescription of AT among European experts. Most cases were recommended AT according to guidelines, but a significant number of patients with genotype Pi*SZ and almost 10% Pi*MZ were recommended to initiate AT despite the lack of evidence of efficacy in these genotypes.